ISRG
Income statement / Annual
Last year (2023), Intuitive Surgical, Inc.'s total revenue was $7.12 B,
an increase of 14.49% from the previous year.
In 2023, Intuitive Surgical, Inc.'s net income was $1.80 B.
See Intuitive Surgical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$7.12 B
|
$6.22 B
|
$5.71 B
|
$4.36 B
|
$4.48 B
|
$3.72 B
|
$3.13 B
|
$2.70 B
|
$2.38 B
|
$2.13 B
|
Cost of Revenue |
$2.39 B |
$2.03 B |
$1.75 B |
$1.50 B |
$1.37 B |
$1.12 B |
$934.80 M |
$814.30 M |
$806.50 M |
$717.90 M |
Gross Profit |
$4.73 B |
$4.20 B |
$3.96 B |
$2.86 B |
$3.11 B |
$2.60 B |
$2.19 B |
$1.89 B |
$1.58 B |
$1.41 B |
Gross Profit Ratio |
0.66 |
0.67 |
0.69 |
0.66 |
0.69 |
0.7 |
0.7 |
0.7 |
0.66 |
0.66 |
Research and Development
Expenses |
$998.80 M
|
$879.00 M
|
$671.00 M
|
$595.10 M
|
$557.30 M
|
$418.10 M
|
$328.60 M
|
$239.60 M
|
$197.40 M
|
$178.00 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$986.60 M
|
$810.90 M
|
$705.30 M
|
$640.50 M
|
$691.00 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$1.96 B
|
$1.74 B
|
$1.47 B
|
$1.22 B
|
$1.18 B
|
$986.60 M
|
$810.90 M
|
$705.30 M
|
$640.50 M
|
$691.00 M
|
Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$2.96 B |
$2.62 B |
$2.14 B |
$1.81 B |
$1.74 B |
$1.40 B |
$1.14 B |
$944.90 M |
$837.90 M |
$869.00 M |
Cost And Expenses |
$5.36 B |
$4.65 B |
$3.89 B |
$3.31 B |
$3.10 B |
$2.52 B |
$2.07 B |
$1.76 B |
$1.64 B |
$1.59 B |
Interest Income |
$192.10 M |
$29.70 M |
$69.30 M |
$157.20 M |
$116.80 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$0.00 |
$29.70 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$435.20 M
|
$380.40 M
|
$317.00 M
|
$282.50 M
|
$199.70 M
|
$120.10 M
|
$95.00 M
|
$88.90 M
|
$89.50 M
|
$74.40 M
|
EBITDA |
$2.19 B
|
$1.58 B
|
$1.82 B
|
$1.05 B
|
$1.37 B
|
$1.20 B
|
$1.05 B
|
$945.20 M
|
$740.00 M
|
$544.80 M
|
EBITDA Ratio |
0.31 |
0.25 |
0.32 |
0.24 |
0.31 |
0.32 |
0.34 |
0.35 |
0.31 |
0.26 |
Operating Income Ratio
|
0.25
|
0.19
|
0.32
|
0.18
|
0.31
|
0.32
|
0.34
|
0.35
|
0.31
|
0.26
|
Total Other
Income/Expenses Net |
$192.10 M
|
$395.50 M
|
$69.30 M
|
$433.40 M
|
$127.70 M
|
$80.10 M
|
$41.90 M
|
$35.60 M
|
$18.50 M
|
$4.20 M
|
Income Before Tax |
$1.96 B |
$1.61 B |
$1.89 B |
$1.21 B |
$1.50 B |
$1.28 B |
$1.10 B |
$980.80 M |
$758.50 M |
$549.00 M |
Income Before Tax Ratio
|
0.27
|
0.26
|
0.33
|
0.28
|
0.34
|
0.34
|
0.35
|
0.36
|
0.32
|
0.26
|
Income Tax Expense |
$141.60 M |
$262.40 M |
$162.20 M |
$140.20 M |
$120.40 M |
$154.50 M |
$436.50 M |
$244.90 M |
$169.70 M |
$130.20 M |
Net Income |
$1.80 B |
$1.32 B |
$1.70 B |
$1.06 B |
$1.38 B |
$1.13 B |
$660.00 M |
$735.90 M |
$588.80 M |
$418.80 M |
Net Income Ratio |
0.25 |
0.21 |
0.3 |
0.24 |
0.31 |
0.3 |
0.21 |
0.27 |
0.25 |
0.2 |
EPS |
5.12 |
3.72 |
4.79 |
3.02 |
3.98 |
3.31 |
1.97 |
2.13 |
1.76 |
1.26 |
EPS Diluted |
5.03 |
3.65 |
4.66 |
2.94 |
3.85 |
3.16 |
1.89 |
2.08 |
1.73 |
1.23 |
Weighted Average Shares
Out |
$351.20 M
|
$355.70 M
|
$356.10 M
|
$351.00 M
|
$346.20 M
|
$341.10 M
|
$335.10 M
|
$344.70 M
|
$333.90 M
|
$332.10 M
|
Weighted Average Shares
Out Diluted |
$357.40 M
|
$362.00 M
|
$365.80 M
|
$360.90 M
|
$358.50 M
|
$356.40 M
|
$348.90 M
|
$353.70 M
|
$341.10 M
|
$339.30 M
|
Link |
|
|
|
|
|
|
|
|
|
|